Print

Alexion Pharmaceuticals Inc. (ALXN) Announces $400 Million Share Repurchase Program  
11/8/2012 10:08:41 AM

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (Alexion or the Company) today announced that the Company’s Board of Directors has authorized the repurchase of up to $400 million of Alexion common stock.
//-->